15 Reviews
CTO and CEO have the right vision. I hope they understand the Engineering teams middle management situation before everyone leaves. Engineering VPs will still figure out a way to blame something else and will not take accountability but only take credit. I really love how the CEO has rallied the company, industry and the Washington around safer OTC regulations.
I am one of the 4 FW/SW managers that left just within last 1 year. Constant road blocks from operations and new quality processes significantly slowed down product development. Cost pressures from manufacturing led to some poor product quality decisions. This is an outcome of having too many directors in manufacturing, sourcing, marketing, quality than any of the software/firmware/hardware functions. If you are in R&D middle management, do not come here !! The VPs just want to keep the R&D managers as front line managers for ever. In contrast, every other department has directors and senior managers with half the experience. Individual contributors from external smaller companies are paid more than FW/SW/HW managers. I left to become a director at a much bigger (20x revenue) company whereas VPs of Engineering treat middle managers as catch-all without promotions. A sourcing director is made VP of HW. A Quality guy who never worked in a med devices deployed an elaborate QMS with no common sense and got promoted. This process still hinders commercial launches.
After 28 years Starkey will retire from the bureau, leaving it in better shape than she found it.
Welcome to Joe Starkey’s mailbag, where the Post-Gazette columnist and 93.7 The Fan radio host answers your questions about sports, life, Lee Flowers...